Skip to content
Shuttingdown

Celularity Inc

Pharmaceutical Preparations · FLORHAM PARK · NJ

Distress signal

Moderate confidence (50%)

Updated Oct 18, 2026, 12:03 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Celularity Inc received a delisting notice from its exchange (Jul 23, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Celularity Inc received a delisting notice from its exchange

    Jul 23, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 23, 2026, Celularity Inc. (the Company ) received notice from the Listing Qualifications department of the Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5450(a)(1) because the closing bid price for the Company s Class A common stock has fallen below $1.00 per share for the last 30 consecutive business days. Nasdaq s…”

  2. Celularity Inc was delisted from its exchange

    Jul 22, 2026

    Delisting effective

    • SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001752828 Celularity Inc 001-38914 1325 Avenue of the Americas 25th Floor New York NY NEW YORK 10019 (212) 616-3700 Warrant 17 CFR 240.12d2-2(a)(2) Katelin Rowe CDO Analyst 2026-07-22”

  3. Celularity Inc received a delisting notice from its exchange

    Jun 9, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On June 9, 2026, Celularity Inc. (the Company ) received written notice (the Notice ) from the Listing Qualifications Staff (the Staff ) of the Nasdaq Stock Market, LLC ( Nasdaq ) notifying the Company that for the last 30 consecutive business days prior to the date of the Notice, the Company s minimum Market Value of Listed Securities was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the MVLS…”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
Listing
SEC lists the ticker CELU on Nasdaq.
SEC CIK
0001752828
Website
—
LinkedIn
—
Headquarters
FLORHAM PARK, NJ
Also known as
GX Acquisition Corp.
Legal entities
Celularity Inc

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Celularity Inc — Pharmaceutical Preparations (SIC 2834) — FLORHAM PARK, NJ
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 23, 2026, Celularity Inc. (the Company ) received notice from the Listing Qualifications department of the Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5450(a)(1) because the closing bid price for the Company s Class A common stock has fallen below $1.00 per share for the last 30 consecutive business days. Nasdaq s…
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    X0203 0001354457 Nasdaq Stock Market LLC 0001752828 Celularity Inc 001-38914 1325 Avenue of the Americas 25th Floor New York NY NEW YORK 10019 (212) 616-3700 Warrant 17 CFR 240.12d2-2(a)(2) Katelin Rowe CDO Analyst 2026-07-22
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On June 9, 2026, Celularity Inc. (the Company ) received written notice (the Notice ) from the Listing Qualifications Staff (the Staff ) of the Nasdaq Stock Market, LLC ( Nasdaq ) notifying the Company that for the last 30 consecutive business days prior to the date of the Notice, the Company s minimum Market Value of Listed Securities was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2) (the MVLS…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:29 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:13 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:15 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:27 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:27 AM

    The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:12 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.